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Abstract
Background: A pair of dizygotic twins discordantly affected by heavy prenatal al-
cohol exposure (PAE) was reported previously by Riikonen, suggesting the role of 
genetic risk or protective factors in the etiology of alcohol-induced developmental 
disorders. Now, we have re-examined these 25-year-old twins and explored genetic 
origin of the phenotypic discordancy reminiscent with fetal alcohol syndrome (FAS). 
Furthermore, we explored alterations in DNA methylation profile of imprinting con-
trol region at growth-related insulin-like growth factor 2 (IGF2)/H19 locus in twins' 
white blood cells (WBC), which have been associated earlier with alcohol-induced 
genotype-specific changes in placental tissue.
Methods: Microarray-based comparative genomic hybridization (aCGH) was used 
to detect potential submicroscopic chromosomal abnormalities, and developmental 
as well as phenotypic information about twins were collected. Traditional bisulfite 
sequencing was used for DNA methylation analysis.
Results: Microarray-based comparative genomic hybridization revealed a microde-
letion 18q12.3-q21.1. in affected twin, residing in a known 18q deletion syndrome 
region. This syndrome has been associated with growth restriction, developmental 
delay or intellectual deficiency, and abnormal facial features in previous studies, 
and thus likely explains the phenotypic discordancy between the twins. We did not 
observe association between WBCs’ DNA methylation profile and PAE, but inter-
estingly, a trend of decreased DNA methylation at the imprinting control region was 
seen in the twin with prenatal growth retardation at birth.
Conclusions: The microdeletion emphasizes the importance of adequate chromo-
somal testing in examining the etiology of complex alcohol-induced developmental 
disorders. Furthermore, the genotype-specific decreased DNA methylation at the 
IGF2/H19 locus cannot be considered as a biological mark for PAE in adult WBCs.
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1 |  INTRODUCTION
Fetal alcohol spectrum disorders (FASDs) are a consequence 
of prenatal alcohol exposure (PAE), and an umbrella term 
for all alcohol-related neurodevelopmental disorders and 
birth defects. The most severe form of FASD is fetal alco-
hol syndrome (FAS), with growth restriction, craniofacial 
dysmorphology, and central nervous system defects. In ad-
dition to timing, the amount and frequency of alcohol expo-
sure also genetic background of fetus affects the vulnerability 
to the teratogenic effects of PAE (Eberhart & Parnell, 2016; 
Mead & Sarkar, 2014). Several twin studies have suggested 
that genetic factors, susceptibility or resistance alleles, 
could affect the severity of phenotype (Hemingway et al., 
2018; Streissguth & Dehaene, 1993). However, any cau-
sality between a genetic factor, molecular mechanism, and 
the phenotype has not been identified so far. In our recent 
study, we observed a single-nucleotide polymorphism (SNP) 
rs10732516 (NC_000011.10:g.1999976G > A) at the regu-
lation region of insulin-like growth factor 2 (IGF2) (OMIM 
*147,470)/H19 imprinted maternally expressed transcript 
(H19) (OMIM *103,280) locus which associates in par-
ent-of-origin manner with altered placental DNA methyla-
tion and phenotype of alcohol-exposed newborns (Marjonen, 
Kahila, & Kaminen-Ahola, 2017). However, the functionality 
of this SNP has not been yet revealed.
We have re-examined a discordant twin pair reported 
by Riikonen (1994) to reveal the genetic background of 
the phenotypic discordancy. The 26-year-old mother of 
the twins was a heavy consumer of alcohol, which was re-
ported by personal interview (RR). The mother of four (P4) 
consumed 10 bottles of beer almost daily (120  g of pure 
alcohol) throughout the second half, but not during the first 
half of pregnancy. However, it is not clear when the preg-
nancy was recognized and alcohol consumption broken off. 
Twins were delivered by cesarean section at the 38th gesta-
tional week due to breech presentation of twin B. The preg-
nancy was otherwise unremarkable and the mother did not 
use drugs. The placenta was characterized by dichorionic 
twinning. Early characteristics of dizygotic twins can be 
seen in Table 1. Twin B fulfilled the criteria of FAS: pre-
natal growth retardation, slow psychomotor development 
as well as minor abnormalities, and stigmata of the face 
(Riikonen, 1994).
Toxic effect of alcohol is caused partly by its oxida-
tion product acetaldehyde, which is highly reactive toward 
DNA, and consequently damages chromosomes and mutates 
stem cells (Garaycoechea et al., 2018; Wang et al., 2000). 
Hence it is not surprising that in recent studies, 13%–14% 
of individuals diagnosed with FASD had chromosomal de-
letions and duplications that could at least partly explain the 
FASD-associated features (Jamuar, Picker, & Stoler, 2018; 
Zarrei et al., 2018). G-banding of chromosomes was done 
for twin B right after the birth to detect potential chromo-
somal arrangements, but the karyotype was normal, 46, XX. 
To improve the resolution of the chromosomal analysis, we 
performed microarray-based comparative genomic hybrid-
ization (aCGH) that allows detecting as small as 50–200 kb 
copy number variations.
In addition to genetic differences, we were interested in 
PAE-induced epigenetic alterations, which have been ob-
served in several previous studies (Kaminen-Ahola et al., 
2010; Marjonen et al., 2017; Portales-Casamar et al., 2016). 
In our recent study, we explored the effects of PAE on im-
printed IGF2/H19 locus on chromosome 11p15.5 (Figure 
1a). This locus is essential for normal embryonic and pla-
cental growth and the two genes are reciprocally imprinted: 
IGF2, a growth promoter, is silenced in maternal allele, 
whereas H19, a negative growth controller, is silenced in 
paternal allele (DeChiara, Robertson, & Efstratiadis, 1991; 
Gabory et al., 2009). The IGF2/H19 imprinting control 
region regulates the function of the locus by containing 
binding sequence for CTCF zinc finger regulatory protein 
(Phillips & Corces, 2009). This sixth CTCF binding site, 
which contains the observed polymorphism rs10732516 
G/A, is normally hypomethylated in maternal and hy-
permethylated in paternal allele (Figure 1a). Decreased 
methylation level of this region has been detected often in 
Silver–Russell syndrome with slow growth (Peñaherrera 
et al., 2010). Interestingly, when examining methylation 
level in heterozygous paternal (pat) G/maternal (mat) A 
and patA/matG placentas, we observed decreased methyla-
tion level only in paternal allele of patA/matG genotype in 
alcohol-exposed placentas (Marjonen et al., 2017). We also 
saw an association between the genotype and head circum-
ference (HC) of newborns, which is extremely interesting 
since the HC has been used in the diagnosis of FASD.
Surprisingly, both of the twins have this particular 
rs10732516 patA/matG genotype and thus we studied 
whether alcohol-induced genotype-specific decreased meth-
ylation level at IGF2/H19 locus could be detected in their 
white blood cells (WBCs). Furthermore, we examined the 
association between the methylation level of this genotype 
and retarded growth: owing to the restricted growth in FASD 
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phenotype, we explored if similar decreased methylation 
level could be seen in addition to alcohol-exposed placentas 
(Marjonen et al., 2017) also in twin B who had growth-re-
stricted phenotype at birth.
2 |  MATERIALS AND METHODS
Informed consent was obtained from participants and 
as a guardian, twin A gave a consent on behalf of twin 
B. The study was approved by the Ethics Committee of 
Helsinki University Central Hospital (HUS/1778/2016 and 
386/13/03/03/2012).
2.1 | DNA extraction
White blood cells' DNA of five healthy control women 
(age 33  ±  5,6  years) was extracted from frozen blood 
samples using NucleoSpin Blood Kit (Macherey-Nagel, 
Düren) according to the manufacturer's protocol. WBCs 
of twins were extracted from fresh blood samples (de-
scribed in Marjonen et al., 2018). WBC DNA for molecu-
lar karyotyping and methylation analysis was extracted 
by AllPrep DNA/RNA/miRNA Universal Kit according 
to the manufacturer's protocol (Qiagen, Valencia). The 
extraction of placental DNA is described in Marjonen 
et al. (2017).
T A B L E  1  Differences in early neurological development, gross and fine motor, psychosocial, and facial features of the twins according to 
Riikonen (1994)
  Twin A Twin B
Early neurological development   After delivery, jitteriness and irritability for 24 hr
At 11 months of age, computed tomography (CT) scan of the head 
showed enlarged cerebral ventricles and moderate cortical and 
cerebellar atrophy
EEG study showed moderate universal disturbances, but no 
epileptiformic episodes.
Year 1994, MRI showed no significant structural anomalies of the 
cranium, maturation of the white substance of the brain was retarded
Gross motor
Stands and walks without support 11 months  
Stands with support   14 months
Walks with support   17 months
Walks without support   2 years
    Increased muscle tone in legs, toe-standing, truncal hypotonia, ataxia
Fine motor
Forefinger-thumb grasping 8 months Grasps with whole hand at 17 months
Psychosocial
Social smile 8 weeks 10 months
Monotonic vocalization   10 months
Says two clear words 14 months  
Two different sounds, no babbling or speech imitation 17 months
Plays interactive games 14 months  
Throws toys   17 months
Likes adult to show book, long babbling 
conversation
17 months  
Two different sounds, no babbling   17 months
Difficult separation of mother   17 months
Facial features Normal 
features
The most prominent craniofacial features included right-sided flat 
occiput, short palpebral fissures (1.9 cm), thin upper lip, long philtrum 
(1.5 cm), and maxillary and mandibular hypoplasia
Facial features remind FAS phenotype
Social situation
Taken into custody by the social welfare board 3 months 3 months
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(a)
(b)
(c)
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2.2 | Comparative genomic 
hybridization array
Microarray-based comparative genomic hybridization 
was done in the laboratory of Helsinki University Hospital 
(HUSLAB) using the Agilent Human Genome CGH 
Microarray Kit 180K (Agilent Technologies Inc.). Data 
analysis was performed using Agilent Cytogenomics ver-
sion 4.0.3.12. All nucleotide positions refer to the Human 
Genome Feb 2009 Assembly (GRCh37/hg19). Those copy 
number variations (deletions or duplications) that are cate-
gorized as clinically irrelevant at the Database of Genomic 
Variants (http://proje cts.tcag.ca/varia tion) were not reported.
2.3 | Genotyping and H19 ICR methylation 
profile analysis by bisulfite sequencing
To find out the genotypes as well as the methylation profile 
at the CTCF6 at H19 ICR (NC_000011.10) of twins, we per-
formed bisulfite sequencing. Due to imprinting, the paternal 
and maternal alleles could be distinguished by sequencing 
method. Two separate bisulfite conversions were performed 
for 500  ng of genomic DNA (EZ DNA Methylation™ kit, 
Zymo Research, Irvine) and pooled afterwards. To avoid possi-
ble PCR bias, three independent 20 μl PCR reactions (HotStar 
PCR kit, Qiagen, Valencia) were performed per sample. 
Primers were obtained from previous publication to detect the 
polymorphism (Coolen, Statham, Gardiner-Garden, & Clark, 
2007). PCR reactions were gel isolated, and the three reactions 
of each sample were pooled and purified using NucleoSpin Gel 
and PCR Clean-up Kit (Macherey-Nagel, Düren). The puri-
fied PCR fragments were ligated into pGEM®-T Easy Vector 
(Promega, Madison) and cloned by standard protocol. The 
recombinant DNA clones were purified using NucleoSpin® 
Plasmid EasyPure kit (Macherey-Nagel, Düren). On average, 
124 clones of both twins were sequenced. The sequences were 
analyzed by BIQ Analyzer (Bock et al., 2005) excluding the 
clones with lower than 90% conversion rate from the dataset.
Since twins were patA/matG genotype, bisulfite sequenc-
ing was also performed for five patA/matG control women 
(50–60 clones per woman) for comparison. Moreover, twins 
were also compared to eight patA/matG alcohol-exposed and 
six control placental methylation profiles obtained from our 
previous publication (Marjonen et al., 2017).
3 |  RESULTS
3.1 | Molecular karyotyping
Microarray-based comparative genomic hybridization re-
vealed that twin A had a normal, but twin B an abnormal kar-
yotype arr(GRCh37) 18q12.3-q21.1 (38,902,336–46,551,876)
x1. There was no indication of mosaicism. The deletions of the 
long arm of chromosome 18 are typically de novo mutations 
with an incidence of 1 in 40,000 live births (Cody et al., 1999). 
18q deletion syndrome (OMIM#601808) is characterized in 
the literature and the phenotype is highly variable depending 
on the size, location, and gene content of the deletion. The 
most common phenotypical features are intellectual disability, 
short stature, characteristic facial dysmorphism, cleft lip or 
palate, delayed myelination, foot deformities, and congenital 
aural atresia (Cody et al., 1999, 2015; Feenstra et al., 2007).
The observed clinically significant 7.65  Mb microdele-
tion consists of 48 genes, of which 28 genes encode Ensembl 
gene producing proteins (gene, *OMIM); phosphatidylinositol 
3-kinase catalytic subunit type 3 (PIK3C3, *602609), Ras-like 
without CAAX 2 (RIT2, *609592), synaptotagmin 4 (SYT4, 
*600103), SET binding protein 1 (SETBP1, *611060), solute 
carrier family 14 member 2 (SLC14A2, *601611), solute car-
rier family 14 member 1 (SLC14A1, *613868), sialic acid bind-
ing Ig-like lectin 15 (SIGLEC15, *618105), ectopic P-granules 
autophagy protein 5 homolog (EPG5, *615068), proline-ser-
ine-threonine phosphatase interacting protein 2 (PSTPIP2, 
*616046), ATP synthase F1 subunit alpha (ATP5F1A, 
*164360), HAUS augmin-like complex subunit 1 (HAUS1, 
*608775), chromosome 18 open reading frame 25 (C18orf25), 
ring finger protein 165 (RNF165), lipoxygenase homology 
domains 1 (LOXHD1, *613072), ST8 alpha-N-acetyl-neur-
aminide alpha-2,8-sialyltransferase 5 (ST8SIA5, *607162), 
protein inhibitor of activated STAT 2 (PIAS2, *603567), kat-
anin catalytic subunit A1 like 2 (KATNAL2, *614697), elongin 
A3 family member D (ELOA3D), elongin A3 family mem-
ber B (ELOA3B), elongin A3 (ELOA3), elongin A2 (ELOA2, 
*609522), haloacid dehalogenase-like hydrolase domain con-
taining 2 (HDHD2), immediate early response 3 interacting 
F I G U R E  1  Schematic figure of the insulin-like growth factor 2 (IGF2)/H19 locus on chromosome 11p15.5 as well as methylation profiles in 
both (total) maternal and paternal alleles of imprinting control region at the IGF2/H19 locus in white blood cells (WBCs) and placental tissue. (a) 
CTCF protein binds to the maternal (mat) unmethylated imprinting control region (H19 ICR, NC_000011.10), which blocks the interaction between 
downstream enhancers and the IGF2 promoter, and enables the expression of maternal H19. The methylation of paternal (pat) H19 ICR prevents 
the binding of CTCF protein, allowing access of downstream enhancers to the IGF2 promoter and provoking the expression of paternal IGF2. (b) 
White blood cells of prenatally alcohol-exposed twins compared to control women (average methylation level between five women, error bars 
denote the standard deviation) (c) alcohol-exposed twins discordant to birth weight compared to control and alcohol-exposed placentas (average 
methylation level, error bars denote the standard deviation). Twin B had significantly smaller birth weight compared to twin A
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protein 1 (IER3IP1, *609382), SKI family transcriptional 
corepressor 2 (SKOR2, *617138), SMAD family member 2 
(SMAD2, *601366), zinc finger and BTB domain contain-
ing 7C (ZBTB7C, *616591), cap binding complex dependent 
translation initiation factor (CTIF, *613178), SMAD family 
member 7 (SMAD7, *602932) and two noncoding RNAs, ker-
atoconus gene 6 (KC6), and long intergenic nonprotein coding 
RNA 907 (LINC00907). Mutant forms of seven genes, SETBP1, 
ATP5A1, SLC14A1, EPG5, LOXHD1, IER31P1, SMAD7, are 
causally associated with human disease. Mutations in SETBP1 
are known to cause autosomal dominant mental retardation 
(Coe et al., 2014) and its haploinsufficiency is associated with 
mild neurodevelopmental delay and verbal development delay 
(Marseglia et al., 2012). SYT4 deletion may cause epilepsy at 
the 18q syndrome (Bouquillon et al., 2011).
3.2 | Development of twins
The current phenotype and developmental features of the 
25-year-old twin pair are shown in Table 2. Twin A has a 
normal, active life. The most prominent features of twin 
B are the absence of speech and moderate mental delay. 
The brain magnetic resonance imaging (MRI, 1.5 Tesla 
magnetron, Siemens) done at 3.5  years of age showed 
frontal cortical and cerebellar atrophy and delayed myeli-
nation (Riikonen, Salonen, Partanen, & Verho, 1999). The 
Wechsler preschool and primary scale of intelligence test 
(WPPSI-R) and peabody picture vocabulary test (PPVT) 
performed at 17 years of age showed universally low ca-
pacity (verbal comprehension, performance, and full-scale 
IQ < 3.3). Previous research on chromosome 18q deletion 
phenotypes has shown central nervous system dysmyeli-
nation, expressive speech impairment, and intellectual 
disability of variable degree (Cody et al., 2015; Feenstra 
et al., 2007; Marseglia et al., 2012; Bouquillon et al., 
2011; Linnankivi et al., 2006). Twin B has minor dysmor-
phic features like thin upper lip, short palpebral fissures, 
wide nasal bridge, slightly triangular shaped face, absent 
fingertips, clinodactyly of the fifth digit, and mild syndac-
tyly of second and third digits but no major anomalies. All 
these minor dysmorphic features are described in previous 
T A B L E  2  The current developmental and phenotypic features of the twins
  Twin A Twin B
Motor Normal developmental milestones Walking at 2 years, stumbles
Fine motor Normal Grapho-motoric tasks, object assembly limited (level of 3 years of 
age), clumsy in use of hands
Cognition Normal Moderately mentally delayed
Speech Verbally talented, large vocabulary No expressive speech, difficulties in verbal concepts
Neuropsychological testing at 14 years: Neuropsychological testing at 17 years: WPPSI*,PPVT**: 
moderately mentally delayed
difficulties in some abstract concepts, 
colors, numbers
Performance IQ is low and comprehension is limited to simplified 
language
Academic skills Normal school, good ranking at 15 years, Severe problems in reading,writing, and numbers
except mathematics Special education, extended compulsary 11 years schedule
Attention problems Yes Yes
Adult life at 25 Qualified as a cook Occupational therapy, horse-riding as a hobby
Independent life No somatic health problems
Living with partner Living in an institution for educationally impaired persons.
Behavior Social, activities Impulsive, cheerful, social adaptation abnormal
  Twin A Twin B
Sex Female Female
Height (cm) at 25 years 163 164.1
Weight (kg) at 25 years 61 70.7
OFC 57 (+2SD) 57.5 (+ 2 SD) n
Dysmorphic features None Slightly triangular face, hypertelorism, short palpebral fissures, 
slight ptosis, wide nasal bridge, thin upper lip mild syndactyly of 
II-III toes
Vision Normal Strabismus
Note: Error OFC: twin B 57.5 (+2SD). PPVT** = peabody picture vocabulary test; WPPSI* = Wechsler preschool and primary scale of intelligence.
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studies of 18q deletion syndrome (Bouquillon et al., 2011; 
Cody et al., 2015; Feenstra et al., 2007; Linnankivi et al., 
2006; Marseglia et al., 2012). Growth restriction was not 
seen after neonatal period (Table 2).
3.3 | DNA methylation at the IGF2/
H19 locus
We next examined potential allele-specific alterations in 
DNA methylation at H19 ICR of IGF2/H19 locus in white 
blood cells. We screened 27 CpG sites on CTCF6, a sixth 
binding site of CTCF zinc finger regulatory protein, using 
traditional bisulfite sequencing. When we compared meth-
ylation profiles of twins to profiles of five control women, we 
did not observe alcohol-induced alterations in WBCs (Figure 
1b). In addition to alcohol-induced alterations in DNA meth-
ylation, we explored potential association between methyla-
tion level and growth. Hence, the average birth weight of 
alcohol-exposed newborns is smaller compared to controls 
and twin B was remarkably smaller at birth compared to 
twin A; we compared the methylation profile of control and 
alcohol-exposed placentas examined in our previous study 
(Marjonen et al., 2017) and both twins (Figure 1c). Twin B 
has lower methylation level in majority of CpG sites in pa-
ternal allele compared to twin A, similarly as the alcohol-
exposed placentas compared to controls. However, more 
growth-discordant twin samples are needed to show associa-
tion between the methylation level of this specific region in 
WBCs and growth.
4 |  DISCUSSION
Several twin studies have shown different fetal susceptibility 
to the effects of alcohol. The mechanism could be connected 
to the structure of placental blood vessels, unequal placen-
tal sharing of monozygotic twins, different rates of organo-
genesis, or differences in ethanol degradation (Guilliam & 
Irtenkauf, 1990). However, studies with monozygotic and 
dizygotic twins suggest that there is also a genetic component 
with risk and protective alleles in the etiology of discordant 
phenotypes.
In this study, we examined genetic differences be-
tween the dizygotic twins discordant to FAS phenotype. 
The karyotype of twin B was tested in 1993 by G-banding 
with normal results. We performed aCGH for both twins 
to gain higher resolution, and we observed a clinically sig-
nificant 18q12.3-q21.1 microdeletion in severely affected 
twin B. This is a plausible explanation for notable, per-
manent differences in the development and phenotype of 
twins. The phenotype of 18q deletion syndrome is highly 
variable (Feenstra et al., 2007; Linnankivi et al., 2006) and 
overlaps with FASD or FAS phenotype with neuronal dis-
orders, growth restriction, and birth defects. Hence it is not 
possible to determine the separate effects of PAE and the 
microdeletion on twin B phenotype.
The microdeletion can be a consequence of heavy mater-
nal alcohol consumption. Alcohol exposure, more specifi-
cally acetaldehyde, can damage chromosomes in oocytes or 
in early embryos before pregnancy have been noticed. We did 
not observe mosaicism of the microdeletion in leukocytes, 
which suggests that de novo mutation could have been oc-
curred already in gametes. However, without parental DNA 
samples and other tissue samples of affected twin, the origin 
of the mutation and the potential cell type-specific mosaicism 
remain vague. Increased incidence of chromosomal arrange-
ments has been found in FASD individuals (Douzgou et al., 
2012; Zarrei et al., 2018). Interestingly, one of 12 children 
diagnosed with FASD by Zarrei et al. (2018) had a dupli-
cation in chromosome 18q12.1. This increased incidence of 
abnormal chromosomal structures might be explained also 
by DNA hypomethylation (Robertson, 2005). It has been 
suggested that alcohol consumption decreases the amount of 
folate, which is needed for cells’ methionine cycle (Halsted 
et al., 1996). Thus, alcohol could reduce the production of 
methyl groups for DNA and histone methylation, cause hy-
pomethylation, and consequently decrease the stability of the 
chromosomes.
Recently, we have observed genotype-specific decreased 
DNA methylation level in IGF2/H19 locus in both alco-
hol-exposed and in vitro fertilized (IVF)-derived placentas, 
which suggest differences in sensitivity to the effects of en-
vironmental factors between the genotypes (Marjonen et al., 
2018, 2017). Both of the twins have this specific rs10732516 
patA/matG genotype where decreased methylation level was 
detected, and we examined if these PAE-associated changes 
could be seen also in their WBCs. Those alterations could be 
used as biomarkers in the diagnostics of alcohol-induced dis-
orders. We explored the effects of PAE on WBCs of twins 
and five healthy women as controls, but we did not observe 
associations between PAE and methylation level. This is in 
line with our previous study, in which IVF treatment was a 
prenatal environmental factor affecting birth weight. We ob-
served genotype-specific association between IVF treatment 
and decreased DNA methylation in this region in placenta, but 
the difference was not seen in WBCs of newborns (Marjonen 
et al., 2018). Furthermore, in the previous IVF studies without 
genotype-specific approach, hypomethylation in placentas, 
buccal cells and mononuclear cells of cord blood have been 
observed, but not in WBCs (Castillo-Fernandez et al., 2017; 
Loke, Galati, Saffery, & Craig, 2015; Nelissen et al., 2013). 
This could be explained by the diverse methylation profiles of 
cell types in WBC samples.
Owing to the essential role of IGF2/H19 locus in em-
bryonic and placental growth, we wanted to see if studied 
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twins are discordant in both birth size and methylation level. 
Interestingly, twin B who had significantly smaller birth 
weight had lower methylation level in majority of CpG sites 
compared to twin A who had normal birth weight. We saw 
this similar trend when we compared alcohol-exposed pla-
centas to controls in our previous study by Marjonen et al. 
(2017). Due to the known association between PAE and re-
tarded growth as well as this observed association between 
PAE and decreased placental DNA methylation, decreased 
methylation in WBCs of twin B could indicate severely re-
tarded growth. Although the direction of methylation changes 
in this regulatory region is similar and could be associated 
with retarded growth in both alcohol-exposed placentas and 
twin B with deletion, alteration in WBCs is subtle and should 
be confirmed with larger number of samples.
Due to the highly variable phenotype of FASD and the 
complex interaction between genome, epigenome, and en-
vironment, the molecular mechanisms causing alcohol-in-
duced developmental disorders are challenging to reveal. 
Contribution of genetic factors to the FASD phenotype can be 
a combination of chromosomal abnormalities, risk/protective 
alleles, and/or epigenetic changes. In attempts to clarify the 
role of genetics in FASD phenotype, it is pivotal to separate 
these factors from each other and therefore, children suspected 
to have FASD should be tested by high-resolution method, like 
aCGH, to exclude identify chromosomal etiologies.
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